Q3 2024 Holdings
Filed 2024-11-14 | 69 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $116.8M | 1,600,000 | 8.9% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $100.3M | 900,000 | 7.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $79.2M | 1,500,000 | 6.0% |
| Inari Medical Inc(NARIUSD) | COM | 45332Y109 | $63.9M | 1,550,000 | 4.8% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $56.4M | 675,000 | 4.3% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $50.5M | 1,150,000 | 3.8% |
| KalVista Pharmaceuticals Inc(KALV) | COM | 483497103 | $46.3M | 4,000,000 | 3.5% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $44.0M | 4,000,000 | 3.3% |
| Immatics NV(IMTX) | SHS | N44445109 | $42.8M | 3,750,000 | 3.2% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $41.7M | 750,000 | 3.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $37.3M | 250,000 | 2.8% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $36.4M | 720,000 | 2.8% |
| Day One Biopharmaceuticals Inc(DAWN) | COM | 23954D109 | $34.8M | 2,500,000 | 2.6% |
| Savara Inc(SVRA) | COM | 805111101 | $34.3M | 8,090,000 | 2.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $33.8M | 760,000 | 2.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $32.5M | 825,000 | 2.5% |
| BioMarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $28.1M | 400,000 | 2.1% |
| Avadel Pharmaceuticals PLCPut | COM SHS | G29687103 | $26.2M | 2,000,000 | 2.0% |
| Biohaven Ltd(BHVN)Call | COM | G1110E107 | $25.0M | 500,000 | 1.9% |
| uniQure NV(QURE) | SHS | N90064101 | $23.4M | 4,750,000 | 1.8% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $22.0M | 485,000 | 1.7% |
| Black Diamond Therapeutics Inc(BDTX) | COM | 09203E105 | $21.9M | 5,028,500 | 1.7% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $19.5M | 2,800,000 | 1.5% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $18.1M | 275,000 | 1.4% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $16.8M | 200,000 | 1.3% |
| Liquidia Corp(LQDA) | COM NEW | 53635D202 | $15.0M | 1,500,000 | 1.1% |
| Agilent Technologies Inc(A) | COM | 00846U101 | $14.8M | 100,000 | 1.1% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $12.9M | 250,000 | 1.0% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $12.3M | 300,000 | 0.9% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $10.8M | 425,000 | 0.8% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $10.8M | 395,000 | 0.8% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $10.5M | 205,000 | 0.8% |
| iTeos Therapeutics Inc(5E7) | COM | 46565G104 | $10.5M | 1,025,000 | 0.8% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $9.7M | 1,145,000 | 0.7% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $9.5M | 425,000 | 0.7% |
| Sanofi SA(SNY) | SPONSORED ADR | 80105N105 | $8.6M | 150,000 | 0.7% |
| Bruker Corp(BRKR) | COM | 116794108 | $8.6M | 125,000 | 0.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $8.0M | 136,500 | 0.6% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $7.7M | 615,000 | 0.6% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $7.7M | 850,000 | 0.6% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $7.6M | 230,000 | 0.6% |
| Alto Neuroscience Inc(ANRO) | COM SHS | 02157Q109 | $7.4M | 650,000 | 0.6% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $7.2M | 30,000 | 0.5% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $6.4M | 30,000 | 0.5% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $6.1M | 125,000 | 0.5% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $5.9M | 1,685,000 | 0.4% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $5.2M | 180,000 | 0.4% |
| UroGen Pharma Ltd(URGN) | COM | M96088105 | $5.1M | 400,000 | 0.4% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $4.9M | 930,000 | 0.4% |
| Geron Corp(GERN) | COM | 374163103 | $4.8M | 1,050,000 | 0.4% |